Cardiff Oncology Inc. Gains 31.61%

Thu, Jun 23, 2022 at 08:30 PM

Cardiff Oncology Inc. (CRDF:NASDAQ) shot up at $2.29, representing a gain of 31.6%. On Thu, Jun 23, 2022, CRDF:NASDAQ touched a New 2-Week High of $2.29. From Thu, Jun 09, 2022, the stock recorded 33.33% Up Days and 50.00% Green Days

The stock spiked on Thu, Jun 09, 2022 at $2.42 with a volume of 8M+.

About Cardiff Oncology Inc. (CRDF:NASDAQ)

Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic...

Top 10 Gainers:

Fujian Blue Hat Interactive Entertainment Technology Ltd. (BHAT:NASDAQ), 263.03%
RISE Education Cayman Ltd (REDU:NASDAQ), 138.46%
F-star Therapeutics Inc. (FSTX:NASDAQ), 59.8%
TDH Holdings, Inc. (PETZ:NASDAQ), 54.74%
Vroom Inc. (VRM:NASDAQ), 36.44%
Rain Therapeutics Inc. (RAIN:NASDAQ), 32.82%
Molecular Data Inc. (MKD:NASDAQ), 32.18%
Cardiff Oncology Inc. (CRDF:NASDAQ), 31.61%
22nd Century Group Inc (XXII:NASDAQ), 31.12%
9 Meters Biopharma, Inc. (NMTR:NASDAQ), 31.11%